KSEV Radio Houston Biogen's experimental lupus drug shows benefit against skin symptoms Gulf Coast • Oct 2, 2026
KXAS NBC Dallas Trinity Christian Academy engineering students use lessons for good Metroplex • Apr 1, 2025
Palestine Herald Press Biogen will stop selling its controversial Alzheimer's drug Aduhelm Upper East Texas • Feb 2, 2024
Weatherford Democrat Biogen will stop selling its controversial Alzheimer's drug Aduhelm Metroplex • Feb 1, 2024
D Magazine | Dallas Plano's Reata Pharmaceuticals Acquired by Biogen for $7.3 Billion Metroplex • Jul 29, 2023
KTBS 3 Texas Biogen to bulk up rare disease treatments with $7 billion Reata acquisition Texas • Jul 28, 2023
My San Antonio | Texas News Biogen to bulk up rare disease treatments with $7 billion Reata acquisition Metroplex • Jul 28, 2023
KTBB Radio Tyler House investigation finds FDA, drug firm Biogen ignored internal concerns for Alzheimer's drug Upper East Texas • Dec 30, 2022
Cleburne Times Review Drug slows Alzheimer's but can it make a real difference? Metroplex • Nov 30, 2022
KTBB Radio Tyler New data shows Alzheimer's drug can slow cognitive decline Upper East Texas • Nov 30, 2022
Waco Tribune Herald Drug slows Alzheimer's but can it make a real difference? Central Texas • Nov 30, 2022
Daily Mail on Texas US STOCKS-S&P 500, Nasdaq pare losses as investors digest Fed comments Texas Non-Local Sources • Nov 14, 2022
Fort Bend Herald and Texas Coaster | Rosenberg Biogen tops 3Q expectations as cost cutting continues Gulf Coast • Oct 25, 2022
Cleburne Times Review Alzheimer's drug shows promise in early results of study Metroplex • Sep 28, 2022
Waco Tribune Herald Alzheimer's drug shows promise in early results of study Central Texas • Sep 28, 2022
Waco Tribune Herald Biogen pays $900M to settle doctor kickback allegations Central Texas • Sep 27, 2022
Fort Bend Herald and Texas Coaster | Rosenberg Global microRNA Industry Report 2022-2027 Featuring Profiles of Thermo Fisher Scientific, Horizon Discovery, QIAGEN, BioGenex, and GeneCopoeia Among Others - ResearchAndMarkets.com Gulf Coast • Jul 13, 2022
Fort Bend Herald and Texas Coaster | Rosenberg Global Anti-Inflammatory Drugs Market (2022 to 2027) - Featuring AbbVie, Amgen and Biogen Among Others - ResearchAndMarkets.com Gulf Coast • Jun 1, 2022
Fort Bend Herald and Texas Coaster | Rosenberg Change at the top for Biogen after Alzheimer's drug flops Gulf Coast • May 3, 2022
Waco Tribune Herald Change at the top for Biogen after Alzheimer's drug flops Central Texas • May 3, 2022
Waco Tribune Herald Biogen's 2022 outlook leaves investors wanting, shares slip Central Texas • Feb 3, 2022
Waco Tribune Herald Biogen tumbles after Medicare lays out Aduhelm coverage plan Central Texas • Jan 12, 2022
Fort Bend Herald and Texas Coaster | Rosenberg Biogen tumbles after Medicare lays out Aduhelm coverage plan Gulf Coast • Jan 12, 2022